Indeed, the administration of HPβCD, both systematically and directly into the CNS, has shown the greatest disease amelioration in NPC1 mouse and feline models, including the rescue of lethality and improved pathological hallmarks of NPC disease [39,40]. This evidence concerns the gene NPC1 and nasopharyngeal carcinoma.